Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors

Clinical trial NCT03565991 · TERMINATED

Trial details

NCT number: NCT03565991
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors Genes, BRCA 1

Start date: 2018-06-18
Primary completion: 2022-03-28
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.